Moreover, Lin-CD34+ cells from AML V20 patient sample were overall resistant to all tested DSBR inhibitors (Supplementary Fig. S5E) and combinations of the inhibitors did not exert significant anti-leukemia effect when compared to individual inhibitors (Supplementary Fig. S5F–H). This evidence concerns the gene CD34 and acute myeloid leukemia.